Scripta Therapeutics is an Oxford-based biotech developing therapeutics that act on transcription factors, the proteins that govern gene expression and shape cellular identity. The company uses genome-wide mapping, high-content imaging and AI-guided screening to identify molecules that can restore healthy transcriptional networks in diseases such as Alzheimer’s, Parkinson’s and ALS. With a platform designed to uncover upstream drivers of disease, Scripta aims to create transformative, disease-modifying treatments for neurodegeneration and ultimately other age-related conditions.